Skip to main content
$1.09 $0.01 (0.9%)

04:00 PM EDT on 06/30/22

Protalix Biotherapeutics Inc (NYSEMKT:PLX)

CAPS Rating: No stars

A clinical stage biopharmaceutical company that is focused on developing and manufacturing recombinant therapeutic proteins that are produced through its proprietary plant cell system.

Current Price $1.09 Mkt Cap $51.3M
Open $1.08 P/E Ratio 0.00
Prev. Close $1.09 Div. (Yield) $0.00 (0.0%)
Daily Range $1.04 - $1.09 Volume 146,359
52-Wk Range $0.70 - $2.00 Avg. Daily Vol. 260,984

Caps

How do you think NYSEMKT:PLX will perform against the market?

Add Stock to CAPS Watchlist

All Players

148 Outperform
72 Underperform
 

All-Star Players

10 Outperform
22 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSEMKT:PLX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Paul8888888 (< 20)
Submitted January 23, 2016

It is outperforming the market. Volume low. Nobody is panicking.

TMFBiologyFool (77.01)
Submitted May 02, 2012

Low patient numbers + 2 competitors = tough launch.I actually like the manufacturing technology, but next drug is still years away.

Fools bullish on NYSEMKT:PLX are also bullish on:

Fools bearish on NYSEMKT:PLX are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about PLX.

Recs

1
Member Avatar Paul8888888 (< 20) Submitted: 1/23/2016 2:31:12 PM : Outperform Start Price: $0.86 NYSE MKT:PLX Score: -73.64

It is outperforming the market. Volume low. Nobody is panicking.

Recs

0
Member Avatar SqwiiTrader (< 20) Submitted: 11/5/2013 2:56:24 PM : Outperform Start Price: $4.40 NYSE MKT:PLX Score: -189.05

IHS pattern

Recs

2
Member Avatar TMFBiologyFool (77.01) Submitted: 5/2/2012 12:24:24 PM : Underperform Start Price: $7.02 NYSE MKT:PLX Score: +253.70

Low patient numbers + 2 competitors = tough launch.

I actually like the manufacturing technology, but next drug is still years away.

Leaderboard

Find the members with the highest scoring picks in PLX.

Score Leader

midastouch017

midastouch017 (< 20) Score: +735.37

For those who believe the biosimilar sector will enjoy a robust bright future, PLX is a wise bet

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
1or5stars 99.47 2/10/2009 Underperform 3W $2.66 -59.02% +345.37% +404.39 0 Comment
anticitradeshort 27.76 4/20/2009 Underperform NS $2.27 -51.98% +345.98% +397.96 0 Comment
Spelunkin 26.03 11/3/2009 Underperform 5Y $10.39 -89.51% +263.95% +353.46 0 Comment
anticitrademix2 < 20 11/2/2009 Underperform 5Y $9.90 -88.99% +262.59% +351.58 0 Comment
anticitrademix < 20 11/2/2009 Underperform 5Y $9.90 -88.99% +262.59% +351.58 0 Comment
MSFOBV1YH 96.68 11/4/2009 Underperform 5Y $10.93 -90.03% +257.84% +347.87 0 Comment
ModernDayWarrior 27.89 10/29/2009 Underperform 5Y $9.58 -88.62% +258.93% +347.55 0 Comment
mathieugp 25.87 9/28/2009 Underperform 3M $7.87 -86.15% +260.10% +346.25 0 Comment
TrackDuality < 20 11/6/2009 Underperform 5Y $11.89 -90.83% +255.32% +346.15 0 Comment
39272x4 < 20 11/9/2009 Underperform 5Y $12.00 -90.92% +249.75% +340.67 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for PLX.